Sumitomo Mitsui Trust Holdings Inc. Has $81.07 Million Holdings in Illumina, Inc. (ILMN)

Sumitomo Mitsui Trust Holdings Inc. lessened its stake in Illumina, Inc. (NASDAQ:ILMN) by 1.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 406,973 shares of the life sciences company’s stock after selling 7,853 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 0.28% of Illumina worth $81,069,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. Dupont Capital Management Corp purchased a new position in Illumina in the third quarter valued at about $153,000. Advisory Services Network LLC grew its stake in Illumina by 13.0% in the second quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock valued at $134,000 after purchasing an additional 89 shares during the last quarter. Penserra Capital Management LLC grew its stake in Illumina by 13.0% in the second quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock valued at $153,000 after purchasing an additional 102 shares during the last quarter. Paradigm Asset Management Co. LLC grew its stake in Illumina by 5.6% in the second quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock valued at $165,000 after purchasing an additional 50 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. grew its stake in Illumina by 11.3% in the second quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock valued at $171,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 92.70% of the company’s stock.

In other news, SVP Charles Dadswell sold 145 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $205.71, for a total transaction of $29,827.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jay T. Flatley sold 22,540 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $195.21, for a total value of $4,400,033.40. Following the transaction, the director now directly owns 539,176 shares of the company’s stock, valued at $105,252,546.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 172,446 shares of company stock valued at $35,486,114. Corporate insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Sumitomo Mitsui Trust Holdings Inc. Has $81.07 Million Holdings in Illumina, Inc. (ILMN)” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.chaffeybreeze.com/2017/11/17/sumitomo-mitsui-trust-holdings-inc-has-81-07-million-holdings-in-illumina-inc-ilmn.html.

Shares of Illumina, Inc. (NASDAQ ILMN) traded up $3.09 during trading hours on Friday, reaching $208.51. The company’s stock had a trading volume of 563,700 shares, compared to its average volume of 961,646. Illumina, Inc. has a one year low of $119.37 and a one year high of $214.50. The firm has a market capitalization of $29,991.32, a P/E ratio of 60.06, a PEG ratio of 3.39 and a beta of 0.74. The company has a debt-to-equity ratio of 0.41, a current ratio of 4.22 and a quick ratio of 3.73.

Illumina (NASDAQ:ILMN) last announced its quarterly earnings results on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.12. Illumina had a return on equity of 19.42% and a net margin of 30.34%. The company had revenue of $714.00 million during the quarter, compared to the consensus estimate of $692.77 million. During the same period in the previous year, the company posted $0.97 earnings per share. Illumina’s revenue for the quarter was up 17.6% on a year-over-year basis. equities research analysts anticipate that Illumina, Inc. will post 3.75 EPS for the current year.

A number of equities research analysts have recently weighed in on ILMN shares. Vetr upgraded Illumina from a “hold” rating to a “buy” rating and set a $209.78 price target on the stock in a research note on Wednesday, August 9th. Canaccord Genuity upgraded Illumina from a “hold” rating to a “buy” rating and boosted their price target for the stock from $170.00 to $215.00 in a research note on Monday, August 7th. Zacks Investment Research upgraded Illumina from a “hold” rating to a “buy” rating and set a $195.00 price target on the stock in a research note on Thursday, July 27th. Argus boosted their price target on Illumina from $205.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, September 13th. Finally, Deutsche Bank AG upgraded Illumina from a “hold” rating to a “buy” rating and dropped their price target for the stock from $195.00 to $160.00 in a research note on Monday, October 23rd. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $200.88.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply